Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04705766 · ClinicalTrials.gov registry record
KIDney Injury in Times of COVID-19 (KIDCOV)
A clinical trial of Covid19 and Acute Kidney Injury, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 3
- Study locations
NCT04705766 is a study of Covid19 and Acute Kidney Injury that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 2,000 participants, below the 2,681-participant average among 94 other Covid19 trials with a reported enrollment target (25% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04705766, a study of Covid19 and Acute Kidney Injury, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture the diversity of race/ethnic risk and COVID19 related municipal shelter-in-place guidance, the investigators will enroll COVID19-negative and COVID19-positive samples balanced by race/ethnicity from 3 different states, California, Michigan, and Illinois. Study endpoints will be assayed from urine samples mailed to the study team at 2, 6, and 12 months after their date of PCR test, with no requirement for these individuals to leave their homes to participate.
Conditions Studied
Interventions
- OTHER Urine Collection
Study Locations (3)
California
- UCSF - San Francisco
Illinois
- Rush University - Chicago
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2027-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04705766
The ClinicalTrials.gov registry entry for NCT04705766 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,681-participant average among 94 other Covid19 trials with a reported enrollment target (25% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Urine Collection is the first listed.
NCT04705766 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Illinois, Michigan.
Frequently Asked Questions
What is clinical trial NCT04705766 about?
NCT04705766 is a clinical study titled "KIDney Injury in Times of COVID-19 (KIDCOV)". There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture the diversity of race/ethnic risk and COVID19 related municipal shelter-in-place guidance, the invest...
What is the current status of trial NCT04705766?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2021-03-01. Estimated completion is 2027-03.
What conditions does trial NCT04705766 study?
This clinical trial studies the following conditions: Covid19, Acute Kidney Injury, Corona Virus Infection, SARS-CoV Infection, Kidney Injury.
What interventions are being tested in trial NCT04705766?
The interventions under investigation include: Urine Collection (OTHER).
Who is sponsoring clinical trial NCT04705766?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04705766 being conducted?
This trial has 3 study locations across California, Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.